Brain natriuretic peptide

Sep 02, 2019

Entresto improved measures of heart structure and function in HFrEF patients in new Novartis study; additional data complement findings

Aug 16, 2019

CVRx Receives FDA Approval for World's First Heart Failure Neuromodulation Device

Jul 23, 2019

Ortho Receives CE Mark for Enhanced VITROS® Immunodiagnostic Products NT-proBNP II Assay, an Aid in Diagnosing and Assessing Heart Failure

Mar 26, 2019

Global Cardiac Biomarkers Markets, 2018-2019 & 2019-2024: Focus on Troponins, Myocardial Muscle Creatine Kinase, Myoglobin, Brain Natriuretic Peptide or NT-proBNP & Ischemia Modified Albumin

Nov 11, 2018

New Novartis study supports Entresto as foundational HFrEF therapy and in-hospital initiation in appropriate stabilized heart failure patients

Sep 17, 2018

Cardiac Biomarkers Market Report 2018 - Global Strategic Business Analysis covering 2016-2024

Mar 29, 2018

Abbott Initiates Trial to Evaluate Improved Survival And Outcomes with the CardioMEMS Monitor

Sep 19, 2017

Boston Scientific Announces Positive Late-Breaking Clinical Trial Data for the HeartLogic(TM) Heart Failure Diagnostic